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Objectives This study examined survival after surgical palliation in children with single-ventricle physiology.
Background Contemporary surgical outcomes for the entire population of newborns undergoing single-ventricle palliation are
unclear.
Methods In a single-center review of 499 consecutive patients undergoing univentricular palliation from 1990 to 2008,
predictors of mortality were determined using multivariate risk analysis, stratified for each post-operative stay
and interim states.
Results After 2000, the population comprised more patients with dominant right ventricle (66% vs. 36%) and hyp-
oplastic left heart syndrome (HLHS) (47% vs. 13%). Median age at bidirectional cavopulmonary shunt
(BCPS) decreased from 15 months (10 to 22 months) before 2000 to 4 months (3.3 to 9 months) thereaf-
ter. Survival rates at 1, 5, and 10 years were, respectively, 82% (95% confidence interval [CI]: 79% to 85%),
74% (95% CI: 70% to 78%), and 71% (95% CI: 67% to 75%). Throughout the study, atrioventricular valve
regurgitation (hazard ratio [HR]: 1.8; p  0.008), not having transposition (HR: 2.0; p  0.013), and hetero-
taxia (HR: 2.0; p  0.026) were predictors of mortality. The most potent risk factor was right ventricular
(RV) dominance (HR: 2.2; p  0.001) because of its impact before BCPS. HR for death in patients with RV
dominance went from 2.8 (95% CI: 1.4 to 5.7; p  0.005) before BCPS to 1.0 (95% CI: 0.5 to 2.1; p 
0.98) thereafter. Survival of patients with RV dominance, adjusted for the risk factors noted here, improved
over the study period (p  0.001).
Conclusions Considerable mortality is still observed during the first years of life among patients with single ventricle. RV dom-
inance is the most important risk factor for death but only before BCPS. (J Am Coll Cardiol 2012;59:1178–85)
© 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.11.049Exact expectations of survival into adulthood for patients
born with a univentricular heart remain to be specified.
There have been a large number of publications detailing
outcomes after specific surgical procedures (1–4) and linear
reports for specific conditions (5–7), but they tend to give a
fragmented perspective on this whole population. Currently,
there are only 2 reports examining survival in a longitudinal
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who had not undergone surgical palliation (8). The second
study was a historical one in which contemporary measures of
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the surgical management of hypoplastic left heart syndrome
(HLHS) has been repeatedly reported (5,6,10–12), but it is
unclear whether progress has been limited to this specific
condition. We retrospectively reviewed our experience to
evaluate the contemporary outcomes of patients under-
going surgery for single-ventricle physiology.
Methods
This study was approved by our institutional human re-
search ethics committee. The records of all children born
with a functionally single ventricle between 1990 and 2008
at the Royal Children’s Hospital Melbourne were reviewed.
Follow-up data were gathered from our database and
Patient Characteristics According to EraTable 1 Patient Characteristics According to Era
Overall
(N  499)
Born
Before
2000
(n  265)
Born
After
2000
(n  234)
Demographics
Male/female 309/190 164/101 145/89
Extracardiac defects 87 (17) 37 (14) 50 (21)
Dominant diagnosis
Tricuspid atresia 75 (15) 52 (20) 23 (10)
Double-inlet left ventricle 62 (12) 43 (16) 19 (8)
Double-outlet right ventricle 40 (8) 26 (10) 14 (6)
Complete atrioventricular canal 29 (6) 12 (5) 17 (7)
Pulmonary atresia with intact
ventricular septum
36 (7) 27 (10) 9 (4)
Hypoplastic left heart syndrome 143 (29) 34 (13) 109 (47)
Ebstein’s anomaly of the
tricuspid valve
5 (1) 5 (2) 0 (0)
Complex 103 (21) 66 (25) 37 (16)
Other 6 (1) 0 (0) 6 (3)
Predominant ventricular morphology
Left 210 (42) 142 (54) 68 (29)
Right 250 (50) 96 (36) 154 (66)
Biventricular 30 (6) 19 (7) 11 (5)
Indeterminate 9 (2) 8 (3) 1 (0.5)
Other morphological characteristics
Atrial isomerism 62 (12) 39 (15) 23 (10)
Left 20 13 7
Right 42 26 16
Bilateral superior vena cavae 84 (17) 45 (17) 39 (17)
Common atrioventricular valve 72 (14) 38 (14) 34 (15)
Atrioventricular valve
regurgitation*
66 (13) 30 (11) 36 (15)
Transposition of the great arteries 112 (22) 64 (24) 48 (21)
Hypoplastic aortic arch 209 (42) 65 (25) 144 (62)
Interrupted aortic arch 15 (3) 9 (3) 6 (3)
Coarctation of the aorta 78 (16) 47 (18) 31 (13)
Aortic stenosis 39 (8) 30 (11) 9 (4)
Aortic atresia 85 (17) 19 (7) 66 (28)
Pulmonary stenosis 111 (22) 96 (36) 15 (6)
Pulmonary atresia 83 (17) 50 (19) 33 (14)
Values are n (%) or n. *Moderate or severe atrioventricular valve regurgitation, as defined by
echocardiogram at birth.reports from referring cardiologists. Patients were includedif their anatomy precluded a
biventricular repair. Overseas pa-
tients were excluded.
A total of 543 patients were
identified. Of these, 44 patients
were excluded because they had
died before surgical palliation (n
 38), proceeded directly to
heart transplantation (n  2), or
ad not undergone an operation
t last follow-up (n  4). The remaining 499 patients all
nderwent surgical palliation and constitute the core of this
tudy. Patients’ characteristics are given in Table 1. The
efinition of HLHS was strictly limited to those with aortic
nd mitral hypoplasia or atresia and a small ascending aorta.
omplex cardiac morphology was defined as the presence of
2 major cardiac malformations that could not be grouped
nto a single diagnosis.
We defined neonatal palliation as one of the following
rocedures: Norwood operation, systemic–pulmonary
hunt, pulmonary artery banding procedure, Damus-Kaye-
tansel connection, attempted biventricular repair, total
nomalous pulmonary venous drainage repair, or arterial
Risk Factors for Mortality for Entire CohortTable 2 Risk Factors for Mortality for Entire Cohort
HR p Value 95% CI
Univariate analyses
Atrial isomerism 2.82 0.000 1.87–4.25
Dominant right ventricle 2.26 0.000 1.54–3.32
Atrioventricular valve regurgitation* 2.34 0.000 1.55–3.54
Common atrioventricular valve 2.23 0.000 1.50–3.33
No transposition of great arteries 2.57 0.001 1.49–4.42
Hypoplastic arch 1.58 0.019 1.08–2.33
Aortic atresia 1.56 0.042 1.02–2.41
Bilateral superior vena cavae 1.50 0.059 0.98–2.27
Atrioventricular discordance 0.38 0.060 0.14–1.04
Pulmonary atresia 0.62 0.064 0.38–1.03
Hypoplastic left heart syndrome 1.41 0.089 0.95–2.10
Interrupted inferior vena cava 1.75 0.115 0.87–3.53
Biventricular morphology 1.49 0.169 0.85–2.62
Dextrocardia 1.36 0.300 0.76–2.44
Interrupted aortic arch 1.45 0.378 0.63–3.32
Coarctation of aorta 1.15 0.521 0.75–1.76
Aortic stenosis 1.18 0.581 0.66–2.09
Mesocardia 1.46 0.603 0.35–6.09
Pulmonary stenosis 0.95 0.827 0.59–1.52
Multivariate analysis
Biventricular morphology 1.86 0.086 0.92–3.75
Dominant right ventricle 2.17 0.001 1.39–3.41
Atrioventricular valve regurgitation 1.79 0.008 1.16–2.77
No transposition of great arteries 2.03 0.013 1.16–3.54
Atrial isomerism 1.95 0.026 1.08–3.50
Common atrioventricular valve 1.11 0.717 0.62–1.98
Stratified cox regression analysis was performed. Univariate factors with p 0.05 and HR2.0 or
HR0.5 were selected for inclusion in the multivariate analysis. *Moderate or severe atrioventric-
Abbreviations
and Acronyms
BCPS  bidirectional
cavopulmonary shunt
CI  confidence interval
HLHS  hypoplastic left
heart syndrome
HR  hazards ratioular valve regurgitation, as defined by echocardiogram at
HR  hazard ratio.birth.
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been described previously (1,2).
Statistical analysis. Survival was estimated by using
Kaplan-Meier curves. Patients were considered at-risk from
birth, and risk factors for mortality were investigated by
using Cox regression. The list of variables analyzed to
estimate their effect on mortality is given in Table 2.
Because the patients’ experiences were characterized by
undergoing various step procedures, conventional Cox re-
gression analysis did not seem appropriate. Our study was
characterized by successions of hospital stays to perform
intermediate step operations, during which a peak of mor-
tality could be expected, and intermediate periods between
surgeries during which a more constant rate of death was
expected. To allow for this anticipated difference in instan-
taneous risk of death during and after each of the surgical
procedures, a stratified Cox model was used. In the stratified
model, each patient record was divided into the following
time segments: hospital stay (or up to 30 days) after the
neonatal surgery, interval between neonatal surgery and
bidirectional cavopulmonary shunt (BCPS), hospital stay
(or up to 30 days) after BCPS, and interval between BCPS
Figure 1 Patient Outcomes
The final status of all 499 patients enrolled in the study.and Fontan completion. The lack of mortality during and
after Fontan precluded analysis of risk factors for these time
periods.
The stratified Cox model allows for different instanta-
neous risk of death during and after each surgical procedure
but assumes that the effect of each risk factor remains
constant across stages. To assess differences in relative
hazards at different stages, Cox regressions were performed
separately for each of the 4 stages described here. The
results suggested that effects of risk factors were similar
across the initial hospital stay and survivors of initial surgery
stages, and also across the BCPS hospital stay and survivors
of BCPS stages but differed before and after BCPS. There-
fore, to increase statistical power in these analyses, we
pooled initial hospital stay and survivors of neonatal surgery
into a single stratified Cox model; we did the same for
BCPS hospital stay and survivors of BCPS surgery.
To assess whether survival had improved over time, Cox
regression was used, with calendar time included as an
explicit covariate in the model. One unit of time was set to
the entire 18-year study period, so that the hazard ratio
(HR) for the time covariate refers to the relative hazard of
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with patients at the start of the study period (1990). To
account for changes in the prevalence of risk factors in the
study population over time, these analyses were adjusted for
the dominant mortality risk factors in Table 2. To provide
a consistency check on these continuous time results,
analyses were also undertaken with period of birth as a
covariate, where period of birth refers to birth either before
or after 2000.
All statistical analyses were performed by using Stata
version 11 (Stata Corp., College Station, Texas).
Results
Outcomes. Complete follow-up was obtained for 98% of
patients, with a mean follow-up duration of 6.6 5.3 years.
The surgical procedures performed and patient outcomes
are described in Figure 1 and Table 3. Of the 499 patients
who were offered surgery, 438 underwent a first operation in
the neonatal period at a median age of 7 days (1 to 855
days). There were 57 hospital deaths (hospital mortality
13%).Thirty-three of the 381 hospital survivors of this
neonatal operation died before BCPS at a median age of 5.8
months (1.4 to 90 days). Thirty-two patients underwent an
additional 35 cardiac procedures between hospital discharge
and BCPS.
Of the 499 patients, 382 underwent a BCPS. The
characteristics of these patients are listed in Table 4. The
age at which the BCPS was performed gradually decreased
over the study period, from a median age of 14.8 months for
patients undergoing BCPS during 1990 to 1991 to 3.4
months for patients undergoing BCPS during 2007 to 2008.
Surgical Procedures and MortalitiesTable 3 Surgical Procedures and Mortalities
n
No. of Hos
Death
Neonatal palliation
Norwood procedure 137 28
Systemic-pulmonary shunt 179 10
Pulmonary artery banding 100 8
Damus-Kaye-Stansel connection 15 7
Other 7 4
Total 438 57
BCPS
BCPS 298 9
Bilateral BCPS 60 5
Kawashima operation 12 0
Classic Glenn 10 1
Other 2 0
Total 382 15
Fontan surgery
Atriopulmonary connection 4 0
Lateral tunnel 41 0
Extracardiac conduit 184 3
Total 229 3BCPS  bidirectional cavopulmonary shunt.Two patients required BCPS takedown. Fifteen patients
died during the hospital stay after BCPS (3.9%).
After hospital discharge following BCPS, an additional
28 deaths occurred before Fontan completion. The interim
mortality between BCPS and Fontan completion did not
appreciably improve between the first decade and the second
decade of the study. It was 8.9% (16 of 180 patients)
between 1990 and 1999, and 6.6% (12 of 182 patients)
between 2000 and 2008 (HR  0.8; p  0.55). Sixteen
patients underwent an additional 17 cardiac procedures
before proceeding to Fontan completion.
At last follow-up, 229 of the 499 patients had undergone
Fontan procedure at a median age of 5 years (1.3 to 16.0
years). Operative mortality was 1.3% (3 of 229 patients).
There were no late deaths after Fontan completion during
the study period.
Eleven patients underwent heart transplantation after
univentricular palliation: 1 between neonatal palliation and
BCPS, 7 between BCPS and Fontan, and 3 after the
Fontan procedure. Two patients died after heart transplan-
tation. Three patients were listed for heart transplantation at
the time of the study; all 3 had previously undergone Fontan
surgery.
Survival analysis. The risk of death of the overall popula-
tion was the highest the first 5 years, and after that time,
mortality remained minimal (Fig. 2). Survival rates at 1, 5,
and 10 years were 82% (95% confidence interval [CI]: 79%
to 85%), 74% (95% CI: 70% to 78%), and 71% (95% CI:
67% to 75%), respectively. Survival remained stable there-
after, with 15-year survival holding at 71%.
Results of Cox regression analyses for the whole period
are displayed in Table 2. According to multivariate
Hospital
Mortality (%)
No. of Interstage
Deaths
Interstage
Mortality (%)
20.4 12 11.0
5.6 14 8.3
8.0 4 4.3
46.7 3 37.5
57.1 0 0.0
13.0 33 8.7
3.0 17 5.9
8.3 8 14.5
0.0 2 16.7
10.0 1 11.1
0.0 0 0.0
3.9 28 7.6
0 0 0
0 0 0
1.6 0 0
1.3 0 0pital
s
t
o
0
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ventricular dominance (HR: 2.2; p  0.001), atrioven-
ricular valve regurgitation (HR: 1.8; p  0.008), absence
f transposition of the great arteries (HR: 2.0; p 
.013), and atrial isomerism (HR: 2.0; p  0.026). The
1-, 5-, 10-, and 15-year survival rates for patients born
with single left ventricle were, respectively, 94% (95% CI:
90% to 96%), 87% (95% CI: 82% to 91%), 85% (95% CI:
79% to 89%), and 85% (95% CI: 79% to 89%) compared
with 74% (95% CI: 67% to 79%), 64% (95% CI: 57% to
70%), 60% (95% CI: 53% to 67%), and 60% (95% CI:
53% to 67%) for patients born with single right ventricle.
Results of Cox regression analyses restricted to initial
hospital stay and survivors of neonatal palliation are dis-
played in Table 5. Of the 7 factors identified by using
univariate analysis as potential predictors of mortality, only
right ventricular dominance (HR: 2.8; p  0.005) and atrial
isomerism (HR: 2.8; p  0.002) clearly remained indepen-
Characteristics of Patients Who UnderwentBidi e ional Cavopulmonary Shunt (N  382)Table 4 Ch racteristics of Patients Who UnderwentBidirectional Cavopulmonary Shunt (N  382)
Demographics
Male/female 232/150
Median age at surgery (months) 9.6 (4–16)
Dominant diagnosis
Tricuspid atresia 62 (16)
Double-inlet left ventricle 57 (15)
Double-outlet right ventricle 26 (7)
Complete atrioventricular canal 21 (6)
Pulmonary atresia with intact ventricular septum 27 (7)
Hypoplastic left heart syndrome 101 (26)
Ebstein’s anomaly of the tricuspid valve 5 (1)
Complex 79 (21)
Other 4 (1)
Predominant ventricular morphology
Left 178 (46)
Right 179 (47)
Biventricular 18 (5)
Indeterminate 7 (2)
Other morphological characteristics
Atrial isomerism 39 (10)
Left 15
Right 24
Bilateral superior vena cavae 67 (18)
Interrupted inferior vena cava 15 (4)
Transposition of the great arteries 97 (25)
Atrioventricular valve regurgitation* 43 (11)
Prior staging with neonatal palliation 326 (85)
Neonatal palliation
Norwood procedure 95 (29)
Modified Blalock-Taussig shunt 101 (31)
Pulmonary artery banding 80 (25)
Damus-Kaye-Stansel connection 10 (3)
Central shunt 33 (10)
Other 7 (2)
Values are n or n (%). *Indicatesmoderate or severe atrioventricular valve regurgitation determined
on echocardiogram at birth.dent predictors in the subsequent multivariate analysis.There was moderate evidence for atrioventricular valve
regurgitation (HR: 1.9; p  0.013) being an independent
risk factor, whereas the results for having a hypoplastic arch
(HR: 1.95; p  0.066) and absence of transposition of the
great arteries (HR: 2.0; p 0.074) were inconclusive. There
was no evidence that aortic atresia (HR: 1.2; p  0.53) was
an independent predictor of mortality. In addition, a test of
equality of HRs for dominant right ventricle patients with
and without HLHS revealed no evidence that those with
HLHS fared worse than those without (difference in HR:
–0.31; p  0.76).
Corresponding results for BCPS hospital stay and survi-
vors of BCPS are displayed in Table 6. Univariate analysis
identified common atrioventricular valve (HR: 3.6; p 
0.001), bilateral superior vena cavae (HR: 3.1; p  0.001),
and atrial isomerism (HR: 3.0; p  0.004) as potential risk
factors for mortality post-BCPS. However, due to the
smaller number of deaths after BCPS (Table 3), subsequent
multivariate analysis was inconclusive, with no factors being
clearly identified as predictive of mortality. Most notably,
there was no evidence that dominant right ventricle re-
mained a predictor of mortality after BCPS (HR: 1.0; p 
0.98).
Predictors of mortality remained similar when the
analysis was performed separately on the first or the
second decade of the study (1990 to 1999 vs. 2000 to
2008). HLHS morphology registered as a univariate
predictor of mortality before 2000 (HR: 2.2; p  0.01)
but not thereafter (HR: 1.2; p  0.47). From 2000
onward, there was no difference in survival between
patients diagnosed with HLHS and patients with a
dominant right ventricle of a different morphology (Fig. 2). The
1-, 5-, and 10-year survival rates for HLHS versus non-
HLHS right ventricle were 75% (95% CI: 67% to 83%)
versus 69% (95% CI: 53% to 80%), 70% (95% CI: 61% to
78%) versus 65% (95% CI: 48% to 76%), and 65% (95% CI:
53% to 75%) versus 60% (95% CI: 43% to 73%), respec-
tively.
The era of birth did not influence survival of patients with
dominant left ventricle (HR: 0.7; p  0.55), whereas
patients with dominant right ventricle showed clear im-
provement in survival over time (HR: 0.3; p  0.001).
Results from analyses using decade of birth were consistent
with the continuous time results.
Discussion
The assumption that, in the past 2 decades, there has
been a dramatic improvement in the survival of infants
born with a single ventricle is based on a scarcity of data.
Numerous reports have demonstrated improvements in
outcomes after the Norwood procedure (5,6,13), yet it is
unclear whether these improvements can be extrapolated
to all patients born with a univentricular heart. Similarly,
the low mortality rates after Fontan surgery, reported in
contemporary series, may not accurately reflect mortality
1183JACC Vol. 59, No. 13, 2012 d’Udekem et al.
March 27, 2012:1178–85 RV Dominance and Single-Ventricle Palliationfor the entire surgical palliation process. We have previ-
ously demonstrated that interim mortality between BCPS
and Fontan surgery may be higher than expected, with a
disappointingly low Fontan completion rate (2). Staging
with BCPS before Fontan surgery has become a selection
process, and therefore objective survival of the entire
group of patients born with single-ventricle physiology
has been difficult to quantify. Objective survival data for
single-ventricle patients, which are necessary to counsel
affected families, seem to be missing from current liter-
ature. Two previous studies have shed limited light on
the topic, both pointing to 5- to 10-year survival rates of
close to 60%. The first study was population based and
included all newborns born with single ventricle in Texas
between 1996 and 2003 (8). Their overall results were
worse than those presented in our study because their
series had included patients who did not undergo surgical
palliation. The majority of our patients, who were not
operated on after birth, died because they were denied
surgery. The second study, from South Korea, had a similar
design to ours, but, for historical reasons, the majority of their
patients did not undergo staging with BCPS before Fontan
completion (9). Their results are therefore difficult to compare
with contemporary practices.
Overall survival. The overall survival of the entire pop-
ulation of infants born with single-ventricle physiology is
still disappointingly low. According to our data, 30% of
infants born with a functional single ventricle, who
Figure 2 Kaplan-Meier Survival Curves
Patients were separated into 2 groups according to era of birth. Era 1 consisted o
2008. HLHS  patients with hypoplastic left heart syndrome; LV  patients with a
a diagnosis of HLHS.undergo surgery, will not reach adulthood. These per-spectives clearly differ depending on individual cardiac
morphology. Up to 85% of those born with a dominant
left ventricle may hope to reach adulthood, whereas this
number is only 65% for those born with a dominant right
ventricle. One should not be overconfident that these
outcomes will ineluctably improve in the future. It is
remarkable that, over a period spanning 2 decades, no
improvement in survival was noted in patients with single
left ventricle. Similarly, interstage mortality between
BCPS and Fontan completion did not improve during
the course of the study. Despite the lack of obvious
increase in survival of the entire population, improvement
in the management of these patients cannot be denied, as
we are now operating on a greater number of patients
with more complex diseases and worse prognosis. Be-
tween the first and the second decade, the proportion of
patients with a dominant right ventricle almost doubled,
largely because the number of Norwood procedures for
HLHS quadrupled. Our results confirm the improvement
obtained in recent years with this condition. In our
center, being born with HLHS no longer carries a worse
prognosis than being born with a dominant right ventri-
cle of a different morphology.
Risk factors for mortality. The most striking finding of
the present study is the demonstration of worse survival
among patients with a dominant right ventricle. It has been
previously shown that having a single right ventricle was a
risk factor for adverse outcome after Fontan surgery (4), but
nts born from 1990 to 1999; era 2 consisted of patients born from 2000 to
nant left ventricle; RV no HLHS  patients with a dominant right ventricle but notf patie
domieven this result has been disputed (3,14,15). Until now, no
F
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preceding Fontan procedure (16).
Interestingly, having a dominant right ventricle was only
a risk factor for mortality up to the BCPS stage. One could
use this finding as an argument to perform the BCPS at an
earlier age. We initially decided to decrease the age at which
the BCPS was performed to decrease interstage mortality
between Norwood and BCPS in patients with HLHS.
Before we could gather any clinical evidence, we arbitrarily
set the timing of BCPS at 3 months of age because it
seemed the youngest age at which this procedure could be
performed safely. Because of the success of this policy, we
have progressively extended it to patients with single ven-
tricle of other morphologies.
The remaining risk factors for mortality have been
identified previously. Heterotaxia seriously weakens the
prognosis of these patients. The Toronto team demon-
strated that up to 60% of the patients with right atrial
isomerism and one-half of those with left atrial isomerism
will die before reaching Fontan status (17–19). Meanwhile,
studies have shown that atrioventricular valve regurgitation
before the time of BCPS was associated with increased
mortality, particularly among patients with HLHS (20,21).
inally, it was not surprising to note that the prognosis of
Risk Factors for Mortality After Neonatal SurgeryTable 5 Risk Factors for Mortality After Neonatal Surgery
HR p Value 95% CI
Univariate analyses
Dominant right ventricle 3.47 0.000 2.09–5.76
Atrial isomerism 2.76 0.000 1.68–4.53
Atrioventricular valve regurgitation 2.70 0.000 1.66–4.39
No transposition of great arteries 3.43 0.001 1.65–7.13
Hypoplastic left heart syndrome 2.22 0.001 1.37–3.62
Aortic atresia 2.13 0.003 1.30–3.51
Hypoplastic arch 2.08 0.003 1.28–3.40
Common atrioventricular valve 1.81 0.023 1.08–3.01
Pulmonary atresia 0.73 0.275 0.42–1.28
Atrioventricular discordance 0.59 0.302 0.21–1.61
Pulmonary stenosis 0.72 0.353 0.37–1.43
Biventricular morphology 1.33 0.427 0.66–2.67
Interrupted inferior vena cava 1.43 0.439 0.58–3.56
Interrupted aortic arch 1.36 0.546 0.50–3.73
Coarctation of aorta 0.89 0.692 0.52–1.55
Aortic stenosis 0.93 0.856 0.43–2.03
Dextrocardia 1.07 0.864 0.48–2.37
Bilateral superior vena cavae 0.96 0.890 0.53–1.73
Mesocardia 1.05 0.962 0.15–7.55
Multivariate analysis
Biventricular morphology 2.42 0.060 0.96–6.08
Dominant right ventricle 2.69 0.005 1.35–5.36
Atrial isomerism 2.76 0.002 1.44–5.32
Atrioventricular valve regurgitation 1.92 0.013 1.15–3.20
Hypoplastic arch 1.95 0.066 0.96–3.98
No transposition of great arteries 2.04 0.074 0.93–4.45
Aortic atresia 1.21 0.529 0.66–2.21
CI  confidence interval; HR  hazard ratio.ur patients without transposition was better, as they clearlygathered a larger proportion of patients with dominant left
ventricles.
Study limitations. This study was historical in nature. The
study cohort was a heterogeneous population of patients
undergoing a multistage surgical palliation process. As the
study period spans 18 years, over time the patient popula-
tion and surgical practices have changed. We are now
operating on more patients with dominant right ventricle
and HLHS. In the early 1990s, our patients underwent
BCPS at a much later age because it was the first time that
this procedure was used as a staging procedure before
Fontan procedures in our center. Our initial patients were
therefore older at the time of BCPS. For these reasons, the
results reported have to be considered best estimates and
may not reflect current practices.
Conclusions
Progress in the care of patients born with functional single
ventricle has been achieved, especially in patients with
HLHS. However, considerable mortality is still observed
during the first few years of life. Right ventricular domi-
nance is the most important risk factor for death but only
before BCPS status is reached.
Risk Factors for Mortality After BCPSTable 6 Risk Factors for Mortality After BCPS
HR p Value 95% CI
Univariate analyses
Common atrioventricular valve 3.61 0.000 1.84–7.09
Bilateral superior vena cavae 3.05 0.001 1.60–5.81
Atrial isomerism 3.00 0.004 1.42–6.31
Coarctation of aorta 1.94 0.060 0.97–3.88
Hypoplastic left heart syndrome 0.46 0.081 0.20–1.10
Pulmonary atresia 0.37 0.107 0.11–1.24
Aortic stenosis 1.92 0.141 0.81–4.56
Interrupted inferior vena cava 2.32 0.170 0.70–7.73
Dextrocardia 1.90 0.174 0.75–4.80
Atrioventricular valve regurgitation 1.64 0.242 0.72–3.74
No transposition of great arteries 1.57 0.280 0.69–3.58
Biventricular morphology 1.74 0.297 0.61–4.95
Aortic atresia 0.64 0.369 0.24–1.70
Mesocardia 2.65 0.388 0.29–24.05
Interrupted aortic arch 1.68 0.489 0.39–7.24
Pulmonary stenosis 1.23 0.559 0.61–2.50
Dominant right ventricle 1.18 0.612 0.62–2.26
Hypoplastic arch 0.98 0.949 0.49–1.96
Atrioventricular discordance — — —
Multivariate analysis
Biventricular morphology 1.02 0.976 0.31–3.30
Dominant right ventricle 1.01 0.982 0.49–2.09
Common atrioventricular valve 2.64 0.055 0.98–7.12
Bilateral superior vena cavae 2.05 0.084 0.91–4.61
Atrial isomerism 0.87 0.804 0.28–2.65CI  confidence interval; HR  hazard ratio.
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